13th International Workshop on Waldenström’s Macroglobulinemia
Join Us in Palm Springs, California!
Experience the world’s premier hematology/oncology meeting dedicated to Waldenstrom’s macroglobulinemia: the 13th International Workshop on Waldenstrom’s Macroglobulinemia (IWWM-13).
IWWM-13 will take place October 14–16, 2026, in Palm Springs, California. This year’s venue is the Renaissance Palm Springs Hotel & Conference Center, one of the city’s leading hotels located in the heart of downtown. The property sits within one of Palm Springs’ most historic districts, offering convenient access to renowned museums, vibrant parks and gardens, art galleries, and standout dining experiences.
Onsite registration and check-in will open on Tuesday, October 13 at 14:00 (2:00 PM). Conference sessions will begin on Wednesday, October 14 at 08:00.
Building on the success of IWWM-12, which featured 23 sessions and over 90 presentations, IWWM-13 will deliver a robust scientific program addressing cutting-edge, patient-focused topics, including:
- Prognostic and therapeutic applications of genomic alterations (MYD88, CXCR4, TP53, 6q del, 17p del)
- Integration of newly recognized WM molecular entities (BCL, PCL) in therapy selection and drug development
- Early intervention strategies for high-risk smoldering WM
- Novel signal inhibitors and degraders targeting MYD88, CXCR4, BTK, HCK, IRAK1/4, and BCL2
- Combination therapies with BTK and BCL2 inhibitors
- Cellular therapies including T-cell engagers and CAR T-cells
- Clinical trial outcomes for high-risk WM patients and ongoing WM trials
IWWM-13 will continue to advance future research by hosting a Junior Investigator Poster Session, which will include brief oral presentations. Abstract submissions for poster presentations will open in March 2026.
The Opening Ceremonies will be held on Wednesday, October 14, at the Palm Springs Art Museum, featuring the presentation of the R. Kyle Award and the Peter S. Bing Humanitarian Awards.
The Closing Ceremonies will take place on Friday, October 16, 2026, at the Westin Rancho Mirage, and will include the presentation of the Jan Gosta Waldenstrom Award and the Young Investigator Awards.
Since its inception in 2000, the IWWM has grown substantially, now engaging investigators from more than 35 countries and contributing to over 6,500 publications, many of which originated from the workshops themselves. Research from IWWM participants has been featured in leading journals such as the New England Journal of Medicine, Blood, Clinical Lymphoma Myeloma, Haematologica, British Journal of Haematology, Journal of Clinical Oncology, Leukemia, Nature, and other top-tier publications.
IWWM-13 remains committed to enriching scientific understanding, fostering collaboration, and driving new discoveries that may lead to more effective therapies—and ultimately, a cure—for Waldenstrom’s macroglobulinemia.
Workshop Chairs
Prashant Kapoor, MD
Rochester, MN, USA
Ranjana Advani, MD, PhD
Standford, CA, USA
Stephen Ansell, MD, PhD
Rochester, MN, USA
Steven Treon, MD, PhD
Harvard Medical School
Boston, MA, USA
Scientific Committee
Andrew Branagan, MD, PhD - Mass General Hospital, Boston, MA, US
Christian Buske, MD PhD - University Hosp. Ulm, Ulm, DE
Jorge Castillo, MD - Dana Farber Cancer Institute, Boston, MA, US
Shirley D’Sa, MD, FRCP, FRCPath - Univ. College London Hosp. London, UK
Meletios Dimopoulos, MD - Univ. Of Athens SChl of Medicine, Athens, GR
Eric Durot, MD - Hopital R. Debre, Paris, FR
Hermann Einsele, MD - Universitätsklinikum Wűrzburg, Wűrzburg, DE
Ramon Garcia Sanz, MD PhD - Hosp. University of Salamanca, Salamanca, ES
Moshe Gatt, MD - HMO, Hebrew Univ. of Jerusalem, IL
Irene Ghobrial, MD - Dana Farber Cancer Institute, Boston, MA, US
Efstathios Kastritis, MD - University of Athens, Athens, GR
M.J. Kersten, MD PhD - AMC, University of Amsterdam, Amsterdam, NL
Eva Kimby MD PhD - Karolinska Institute, Stockholm, SE
Sigurdur Kristinsson MD PhD - University of Iceland, Reykjavik, IS
Monique Minnema, MD PhD - UMC Utrecht, Utrecht, NL
Pierre Morel, MD - Centre Hosp. Univ. D’Amiens, Amiens, FR
Nikhil Munshi, MD - Dana Farber Cancer Institute, Boston, MA, US
M.Lia Palomba, MD - Memorial Sloan Kettering Cancer Center, NYC, NY, US
Lugui Qiu, MD - Inst. Of H.B.D. Hosp., CAMS, Tianjin Shi, CN
Damian Roos-Weil, MD - Sorbonne University, Paris, FR
Shayna Sarosiek, MD - Dana Farber Cancer Institute, Boston, MA, US
Naohiro Sekiguchi, MD, PhD - Nat ’l Hosp. Organ. DMC, Tokyo, JP
Romanos Sklavenitis-Pistofidis, MD, PhD - City of Hope, Duarte, CA, US
Constantine Tam, MD, FRACP, FRCPA - University of Melbourne, Melbourne, AUS
Alessandra Tedeschi, MD, PhD - ASST G.O. Metropolitano Niguarda, Milan, IT
Judith Trotman, MD, FRACP, FRCPA - Concord Rep. General Hosp., Concord, AUS
Josephine Vos, MD PhD AMC, - University of Amsterdam, Amsterdam, NL
Shuhua Yi, MD - CAMS-PUMC, Tianjin Shi, CN